title: Advancing personalized cancer medicine in lung cancer.
abstract: Although improvements in genomic technologies during the past decade have greatly advanced our understanding of the genomic alterations that contribute to lung cancer, and the disease has (to a degree) become a paradigm for individualized cancer treatment in solid tumors, additional challenges must be addressed before the goal of personalized cancer therapy can become a reality for lung cancer patients.
authors.affiliation: Department of Pathology, Brigham and Women's Hospital, 450 Brookline Ave., Dana 1539, Boston, MA 02215, USA. laura_macconaill@dfci.harvard.edu
authors.forename: Laura E
authors.initials: LE
authors.lastname: MacConaill
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000628:therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000628:therapy*; D008297:Male; D057285:Precision Medicine / Q000379:methods* / Q000639:trends*